risk factors for isolation of streptococcus pneumoniae with decreased susceptibility to penicillin g from patients infected with human immunodeficiency virus.

NLM AIDSLINE Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus. Meynard JL; Barbut F; Blum L; Guiguet M; Chouaid C; Meyohas MC; Picard
February 28, 1997

Clin Infect Dis. 1996 Mar;22(3):437-40. Unique Identifier : AIDSLINE We conducted a retrospective study of all hospitalized human immunodeficiency virus (HIV)-infected patients from whom a strain of Streptococcus pneumoniae was isolated (n = 45) between January 1992 and September 1994, in order to determine the clinical manifestations and outcome of and risk factors for infection by S. pneumoniae with decreased susceptibility to penicillin G. Such strains were isolated from 14 patients (31%), of whom 8 had pneumonia, 2 had bronchial superinfection, 2 had sinusitis, and 2 were colonized. All infected patients made a clinical recovery regardless of the MIC of the isolate. Indexes of HIV disease stage (CD4+ cell count and p24 antigenemia), antiretroviral treatment, and hospital admission in the previous 3 months did not influence the susceptibility of the isolates. For HIV-infected patients, treatment with antibacterial agents--particularly trimethoprim-sulfamethoxazole--in the previous 3 months is associated with an increased risk for isolation of S. pneumoniae with decreased susceptibility to penicillin G (relative risk, 5.0; 95% confidence interval, 1.9-13.3). Adult AIDS-Related Opportunistic Infections/COMPLICATIONS/DRUG THERAPY/ MICROBIOLOGY Female Human Male Middle Age Penicillin G/THERAPEUTIC USE Penicillin Resistance Pneumococcal Infections/COMPLICATIONS/DRUG THERAPY/MICROBIOLOGY Retrospective Studies Risk Factors Streptococcus pneumoniae/*DRUG EFFECTS/ISOLATION & PURIF JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 NORTH DAKOTA: Officials: 26 Tuberculosis Cases from Grand Forks Outbreak AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common CANADA: Nunavut Uses Comic Book to Do Sex Education NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing UNITED STATES: Hepatitis C Testing for People Born Between 1945 and 1965 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV HIV-infected teacher's aide accused of molestation Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic(R), SB-728-T Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research: June 14, 2013 Antiretroviral regimen associated with less virological failure among HIV-infected children Legal help for AIDS patients WASHINGTON: Free Hepatitis Testing for At-Risk Individuals UNITED STATES: Pretreatment Anemia Raises Mortality Risk Among HCV/HIV Coinfected Patients New Research Uncovers Willful Misrepresentation of Medical Data in Creation of AIDS "Patient Zero" Myth GEORGIA: Director of AIDS Athens 'Inspired' from Helping Her Patients ITALY: HIV Meds Protect Against Doubled Cancer Risk in Positive Men
Information in this article was accurate in February 28, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.